New Alzheimer's Association research grants accelerate studies of potential drug therapies

(Alzheimer's Association) Many academic researchers and pharmaceutical companies have identified new Alzheimer's drug therapy candidates, but lack the funding to move them into human testing. At the same time, few funding sources support early-phase clinical drug trials. As a result, too many promising studies stall out early in the discovery process. Today, the Alzheimer's Association announces new grant awards for five early-phase clinical trials attempting to span this troublesome gap in rese...